CEO Christopher Missling presented an update on the company’s central nervous system pipeline at the firm’s 46th Annual Healthcare Conference, highlighting late-stage data for its oral Alzheimer’s ...

Gary Clark of Neighbors for a Better Crossing urges Oregon lawmakers to pursue an audit of the Interstate Bridge Replacement ...

A pair of musicals, one featuring the Addams Family and the other showcasing Dorothy and Toto, will hit the stage at two North Fork high schools this weekend.

The case for separating aerospace and defense businesses from broader industrial production has never been stronger, and the drivers are not just activist investors who have championed such splits for ...

FDA review targets ER-positive/HER2-negative, ESR1-mutated advanced disease after endocrine therapy, positioning giredestrant plus everolimus as a potential first oral SERD combination post-CDK4/6 ...

Orban was the clear winner last week: he successfully mobilized support, received international backing, and unwaveringly represented Hungarian interests.

Franklin R. Ciaccio, 83, passed away peacefully on Feb. 14, 2026, on the East End of Long Island, a place he loved dearly. Born in New York City on Oct. 20, 1942, Frank was a lifelong New Yorker, save ...

ITT beat estimated earnings by 3.93%, reporting an EPS of $1.85 versus an estimate of $1.78. Revenue was up $125.00 million from the same period last year. In the previous quarter, the company beat on ...

Exelixis, Inc. (Nasdaq: EXEL) today announced that its New Drug Application (NDA) for zanzalintinib, in combination with atezolizumab (Tecentriq®), has been accepted for review in the U.S. for the ...

The initial Rotten Tomatoes score for Melania Trump's new documentary fell short of her husband's approval ratings, opening at 8%. "Melania" hit theaters nationwide Friday, Jan. 30, following the ...